| A Study of HA121-28 Tablets in Patients With Medullary Thyroid Carcinoma (MTC) (NCT04787328) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2021-07-13 |
| Spanish Study for Molecular Characterization of Thyroid Carcinoma (NCT04970134) | Grupo Español de Tratamiento de Tumores de Cabeza y Cuello | 2021-06-14 |
| Evaluation of 18F-FDOPA PET-CT in the Preoperative Initial Assessment of Medullary Thyroid Carcinoma (NCT03636945) | Assistance Publique Hopitaux De Marseille | 2018-10-01 |
| Calcitonin in Needle Wash Using Electrochemiluminescence Method For Diagnosis Of Medullary Thyroid Carcinoma. (NCT06067594) | Austral University, Argentina | 2018-03-01 |
| Radiolabelled CCK-2/Gastrin Receptor Analogue for Personalized Theranostic Strategy in Advanced MTC (NCT03246659) | Paola Anna Erba | 2016-08-01 |
| Study of Anlotinib in Patients With Medullary Thyroid Carcinoma(ALTER01031) (NCT02586350) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2015-07-01 |
| ImmunoTEP for Patients With Medullary Thyroid Carcinoma. (NCT01730638) | Nantes University Hospital | 2013-01-01 |
| An Active Surveillance Program for Cases of Medullary Thyroid Carcinoma (MTC) (NCT01511393) | Novo Nordisk A/S | 2012-01-01 |
| Study of Molecular Pathways in Medullary Thyroid Carcinoma and Correlation of Molecular Data With Clinical Behavior of the MTC in Individuals Patients (NCT01424878) | National Cancer Institute (NCI) | 2010-07-05 |
| A Targeted Phase I/II Trial of ZD6474 (Vandetanib; ZACTIMA) Plus the Proteasome Inhibitor, Bortezomib (Velcade ), in Adults With Solid Tumors With a Focus on Hereditary or Sporadic, Locally Advanced or Metastatic Medullary Thyroid Cancer (MTC) (NCT00923247) | National Cancer Institute (NCI) | 2009-02-19 |
| Vandetanib to Treat Children and Adolescents With Medullary Thyroid Cancer (NCT00514046) | National Cancer Institute (NCI) | 2007-07-20 |
| Collection of Tissue Samples for Study of Multidrug Resistance (NCT00880503) | National Cancer Institute (NCI) | 2003-12-19 |
| 123I-MIBG Scintigraphy in Patients Being Evaluated for Neuroendocrine Tumors (NCT01373736) | Vancouver Coastal Health | |